StockTipsArenaBeta

BUY Shilpa Medicare Limited — Rajesh Agarwal, AUM Capital

BUYShilpa Medicare Limited
Shilpa Medicare share price target & all analyst calls

byRajesh Agarwal, AUM CapitalHorizon: 1 year31 Aug 2026via NDTV Profit

Entry₹947.95Inferred
Target₹1,100
Total upside +16.04%
Stop lossNot given
CMP₹955.65h ago
Active+0.81%+15.11%upside left 10 mo left
Follow Rajesh Agarwal for new callsGet alertsWatch SHILPAMED for new buy/sell callsGet alertsSee 411 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:24 pm IST
12 supporting8 neutral3 opposing
Supports the BUY call (12)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·30 Oct · today

Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix

NewsCnbc-Tv18·27 Oct · 3d ago

(opens in new tab)

AGES Austria issues GMP certification to Shilpa Medicare’s Jadcherla unit

NewsCnbc-Tv18·10 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (8)

Q2 FY27 results scheduled — board meets 05 Nov 2026

BSE · Board Meeting·In 5 days

(opens in new tab)
Weighs against the BUY call (3)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Shilpa Medicare

All analyst calls on Shilpa Medicare

More from Rajesh Agarwal, AUM Capital

Every call and its outcome